CTI BioPharma to Present at the Cowen 41st Annual Health Care Conference on Thursday, Mar. 4
CTI BioPharma to Present at the Cowen 41st Annual Health Care Conference on Thursday, Mar. 4
February 25, 2021 at 7:00 AM EST
Presentation details:
Event: Cowen 41st Annual
Date:
Time:
The presentation will be webcast live and available for replay from the Investors section of
About
We are a biopharmaceutical company focused on the acquisition, development and commercialization of novel targeted therapies for blood-related cancers that offer a unique benefit to patients and their healthcare providers. We concentrate our efforts on treatments that target blood-related cancers where there is an unmet medical need. In particular, we are focused on evaluating pacritinib, our sole product candidate currently in active late-stage development, for the treatment of adult patients with myelofibrosis. In addition, we have recently started developing pacritinib for use in hospitalized patients with severe COVID-19, in response to the COVID-19 pandemic. We are headquartered in
CTI BioPharma Investor Contacts:
+212-600-1902
View original content to download multimedia:http://www.prnewswire.com/news-releases/cti-biopharma-to-present-at-the-cowen-41st-annual-health-care-conference-on-thursday-mar-4-301235382.html
SOURCE
